Pyrrolidinoindoline alkaloids from selaginella moellendorfii

Journal of Natural Products

Volumn 72, Issue 6, 2009, Pages 1151-1154

  Wang, Yue Hu ^a   Long, Chun Lin ^a,b   Yang, Fu Mei ^c,d   Wang, Xi ^c,d   Sun, Qian Yun ^c,d   Wang, Hong Sheng ^a,e,f   Shi, Ya Na ^a,e   Tang, Gui Hua ^a  

^a KUNMING INSTITUTE OF BOTANY   (China)

^b MINZU UNIVERSITY OF CHINA   (China)

^c Key Laboratory of Chemistry for Natural Products   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e YUNNAN AGRICULTURAL UNIVERSITY   (China)

^f HENAN INSTITUTE OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXY N8,N8 DIMETHYLPSEUDOPHRYNAMINOL; 5 HYDROXYSELAGINELLIC ACID; ACETYLCHOLINESTERASE; INDOLE ALKALOID; METHYL GROUP; N (5 HYDROXYNEOSELAGINELLOYL)PHENYLALANINE; N (5 HYDROXYSELAGINELLOYL)PHENYLALANINE; N NEOSELAGINELLOYLPHENYLALANINE; N SELAGINELLOYLPHENYLALANINE; NEOSELAGINELLIC ACID; PYRROLIDINOINDOLINE ALKALOID DERIVATIVE; SELAGINELLIC ACID; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG ISOLATION; DRUG STRUCTURE; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; SELAGINELLA; SELAGINELLA MOELLENDORFII; STRUCTURE ANALYSIS;

CHOLINESTERASE INHIBITORS; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; ESCHERICHIA COLI; HUMANS; INDOLE ALKALOIDS; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PYRROLIDINES; SELAGINELLACEAE; STAPHYLOCOCCUS AUREUS;

SELAGINELLA MOELLENDORFFII;

EID: 67650216171     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np9001515     Document Type: Article

References (21)

1. Huang, A.; Kodanko, J. J.; Overman, L. E. J. Am. Chem. Soc. 2004, 126, 14043-14053.
2. (a) Yu, Q. S.; Holloway, H. W.; Flippen-Anderson, J. L.; Hoffman, B.; Brossi, A.; Greig, N. H. J. Med. Chem. 2001, 44, 4062-4071.
3. (b) Houghton, P. J.; Ren, Y. H.; Howes, M. J. Nat. Prod. Rep. 2006, 23, 181-199.
4. (c) Rivera-Becerril, E.; Joseph-Nathan, P.; Perez-Alvarez, V. M.; Morales-Rios, M. S. J. Med. Chem. 2008, 51, 5271-5284.
5. Amador, T. A.; Verotta, L.; Nunes, D. S.; Elisabetsky, E. Planta Med. 2000, 66, 770-772.
6. Dix, A. V.; Meseck, C. M.; Lowe, A. J.; Mitchell, M. O. Bioorg. Med. Chem. Lett. 2006, 16, 2522-2524.
7. (a) Chen, D. Z.; Yu, J. G. Zhongcaoyao 1986, 17, 4.
8. (b) Zheng, X. K.; Li, K. K.; Wang, Y. Z.; Feng, W. S. Chin. Chem. Lett. 2008, 19, 79-81.
9. (c) Zhu, T. M.; Chen, K. L.; Zhou, W. B. Chin. Chem. Lett. 2008, 19, 1456-1458.
10. (d) Sun, C. M.; Syu, M. J.; Huang, Y. T.; Chen, C. C.; Ou, J. C. J. Nat. Prod. 1997, 60, 382-384.
11. (e) Shi, S. Y.; Zhou, H. H.; Zhang, Y. P.; Huang, K. L. Chromatographia 2008, 68, 173-178.
12. Spande, T. F.; Edwards, M. W.; Pannell, L. K.; Daly, J. W.; Erspamer, V.; Melchiorri, P. J. Org. Chem. 1988, 53, 1222-1226.
13. Takayama, H.; Matsuda, Y.; Masubuchi, K.; Ishida, A.; Kitajima, M.; Aimi, N. Tetrahedron 2004, 60, 893-900.
14. (a) Shirasaka, T.; Takuma, Y.; Shimpuku, T.; Imaki, N. J. Org. Chem. 1990, 55, 3767-3771.
15. (b) Nakagawa, M.; Maruyama, T.; Hirakoso, K.; Hino, T. Tetrahedron Lett. 1980, 21, 4839-4842.
16. (c) Nakagawa, M.; Kato, S.; Fukazawa, H.; Hasegawa, Y.; Miyazawa, J.; Hino, T. Tetrahedron Lett. 1985, 26, 5871-5874.
17. Xu, S. Y.; Bian, R. L.; Chen, X. Pharmacological Experiment Methodology, 3rd ed.; People's Medical Publishing House: Beijing, 2002; pp 1647-1719.
18. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.
19. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
20. (a) Ellman, G. L.; Courtney, K. D.; Andres, V.; Featherstone, R. M. Biochem. Pharmacol. 1961, 7, 88-95.
21. (b) Rhee, I. K.; Appels, N.; Hofte, B.; Karabatak, B.; Erkelens, C.; Stark, L. M.; Flippin, L. A.; Verpoorte, R. Biol. Pharm. Bull. 2004, 27, 1804-1809.